Table 6 Antimicrobial resistance phenotypes of 49 Salmonella isolates
Antibacterial agents | Number of resistant isolates (%) | Total (n = 49) | ||||
|---|---|---|---|---|---|---|
Sample from | ||||||
Farm 1 (n = 11) | Farm 2 (n = 10) | Farm 3 (n = 8) | Farm 4 (n = 18) | Slaughterhouse (n = 2) | ||
β-Lactams | ||||||
 AMP | 0 | 8 (80.0) | 6 (75.0) | 13(72.2) | 0 | 27 (55.1) |
 CRO | 0 | 5 (50.0) | 2 (25.0) | 1 (5.6) | 0 | 8 (16.3) |
 CTX | 0 | 3 (30.0) | 2 (25.0) | 0 | 0 | 5 (10.2) |
Macrolides | ||||||
 EM | 11 (100.0) | 10 (100.0) | 8 (100.0) | 18 (100.0) | 2 (100.0) | 49 (100.0) |
Aminoglycosides | ||||||
 GEN | 0 | 6 (60.0) | 2 (25.0) | 6 (33.3) | 0 | 14 (28.6) |
 STR | 4 (36.4) | 9 (90.0) | 5 (62.5) | 9 (50.0) | 0 | 27 (55.1) |
Tetracyclines | ||||||
 TET | 0 | 7 (70.0) | 4 (50.0) | 5 (27.8) | 0 | 16 (32.7) |
Sulfonamides | ||||||
 SXT | 0 | 2 (20.0) | 2 (25.0) | 1 (5.6) | 0 | 5 (10.2) |
Quinolones | ||||||
 NOR | 0 | 7 (70.0) | 2 (25.0) | 1 (5.6) | 0 | 10 (20.5) |
 CIP | 0 | 7 (70.0) | 2 (25.0) | 3 (16.7) | 0 | 12 (24.5) |
 NAL | 11 (100.0) | 10 (100.0) | 8 (100.0) | 18 (100.0) | 0 | 47 (95.9) |
Amphenicols | ||||||
 CHL | 0 | 2 (20.0) | 2 (25.0) | 1 (5.6) | 0 | 5 (10.2) |
 FFN | 0 | 2 (20.0) | 2 (25.0) | 1 (5.6) | 0 | 5 (10.2) |
Polypeptide | ||||||
 PB | 0 | 0 | 0 | 0 | 0 | 0 |